---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-21-043472"
form_type: "8-K"
ticker: "RCUS"
cik: "0001724521"
company_name: "Arcus Biosciences, Inc."
filed_at: "2021-08-11T23:59:59+00:00"
generated_at: "2026-06-29T15:19:43.528611+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Arcus board member Quigley resigns; Linda Higgins appointed as Gilead designee

## Summary
- Michael Quigley resigned from Arcus board effective upon appointment of Gilead's new designee, following his departure from Gilead.
- Linda Higgins, SVP of Research at Gilead, appointed as Class III director; she previously led Biology at Gilead since 2010.
- Higgins will not receive compensation for Arcus board service; standard indemnification agreement expected.
- Changes effective August 10, 2021, under the Investor Rights Agreement with Gilead dated May 2020.

## SEC filing metadata
- accession: 0001564590-21-043472
- form_type: 8-K
- ticker: RCUS
- cik: 0001724521
- company_name: Arcus Biosciences, Inc.
- filed_at: 2021-08-11T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1724521/000156459021043472/0001564590-21-043472-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1724521/000156459021043472/rcus-8k_20210810.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-21-043472
- JSON: https://secwatch.observer/filing/0001564590-21-043472.json
- Plain text: https://secwatch.observer/filing/0001564590-21-043472.txt

## Key facts
- Executive change
  Linda Higgins was appointed as Director at Arcus Biosciences, Inc..
  - Action: appointed
  - Role: Director
  source text: On August 10, 2021, the Board appointed Linda Higgins, Senior Vice President of Research, External Innovation at Gilead, as a Class III director to fill the vacancy left by Dr. Quigley’s resignation.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1724521/000156459021043472/0001564590-21-043472-index.htm
- Executive change
  Michael Quigley resigned as Director at Arcus Biosciences, Inc..
  - Action: resigned
  - Role: Director
  source text: Michael Quigley, Ph.D., resigned as a member of Arcus Biosciences, Inc.’s Board of Directors, effective upon the appointment of Gilead’s new director designee
  evidence_url: https://www.sec.gov/Archives/edgar/data/1724521/000156459021043472/0001564590-21-043472-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.